3Q4-32631-62771
2 vaccinations
1 coded response
1 check-in
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 207 / MD
- Registered
- 2021-06-13
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-11
Dose 1 — Pfizer-BioNTech
-
2021-05-02
Dose 2 — Pfizer-BioNTech
-
2021-06-13
Registered in v-safe
-
2021-06-13
Survey response — day 42, dose 2MedDRA: Emergency care, Fatigue, Syncope — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: After receiving my second dose, I've been experiencing extremely tiredness and fatigue. I had several episodes of syncope.I was taken to the emergency department twice with no resolution.I visited my primary care doctor but my symptoms persistedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-13
Report sent to call center — day 42, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-06-15
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-11 | Pfizer-BioNTech | |
| 2 | 2021-05-02 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-13 | Successful 2021-06-15 |
Participant prefers to complete VAERS report online |
Free text
Release 9 — day 42, dose 2
Symptoms: After receiving my second dose, I've been experiencing extremely tiredness and fatigue. I had several episodes of syncope.I was taken to the emergency department twice with no resolution.I visited my primary care doctor but my symptoms persisted
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Emergency care | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Syncope | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release